N. Peter

413 total citations
8 papers, 167 citations indexed

About

N. Peter is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, N. Peter has authored 8 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Hematology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in N. Peter's work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). N. Peter is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). N. Peter collaborates with scholars based in Germany, Switzerland and United States. N. Peter's co-authors include Marcel Reiser, Michael Pfreundschuh, Christina Nickenig, Wolfram Pönisch, Thoralf Lange, Antina Schulze, Dietger Niederwieser, Norbert Schmitz, Markus Loeffler and Rainer Krahl and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

N. Peter

8 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Peter Germany	7	80	60	53	40	28	8	167
P Vivancos Spain	9	137 1.7×	62 1.0×	48 0.9×	36 0.9×	38 1.4×	11	186
Nicola Cantore Italy	9	84 1.1×	41 0.7×	22 0.4×	32 0.8×	44 1.6×	14	158
Anne‐Lise Ménard France	7	104 1.3×	57 0.9×	36 0.7×	58 1.4×	42 1.5×	15	187
Phyllis Warkentin United States	6	72 0.9×	81 1.4×	104 2.0×	94 2.4×	18 0.6×	7	219
Christine Mauz‐Koerholz Germany	5	82 1.0×	75 1.3×	60 1.1×	79 2.0×	13 0.5×	17	190
Andrei Coliţă Romania	7	90 1.1×	24 0.4×	25 0.5×	30 0.8×	54 1.9×	38	153
A von Stackelberg Germany	7	120 1.5×	53 0.9×	161 3.0×	27 0.7×	27 1.0×	13	246
E. Feldman United States	6	120 1.5×	51 0.8×	65 1.2×	24 0.6×	48 1.7×	19	165
Д. С. Абрамов Russia	7	33 0.4×	46 0.8×	28 0.5×	75 1.9×	19 0.7×	56	169
Kirsten Bleckmann Germany	9	120 1.5×	34 0.6×	140 2.6×	26 0.7×	18 0.6×	12	192

Countries citing papers authored by N. Peter

Since Specialization

Citations

This map shows the geographic impact of N. Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Peter more than expected).

Fields of papers citing papers by N. Peter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Peter. The network helps show where N. Peter may publish in the future.

Co-authorship network of co-authors of N. Peter

This figure shows the co-authorship network connecting the top 25 collaborators of N. Peter. A scholar is included among the top collaborators of N. Peter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Peter. N. Peter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Thiel, Andreas, Johannes Schetelig, Wolfram Pönisch, et al.. (2015). Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL). Annals of Oncology. 26(7). 1434–1440. 7 indexed citations

Zwick, C., Frank Hartmann, Samira Zeynalova, et al.. (2011). Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia. Annals of Oncology. 22(8). 1872–1877. 30 indexed citations

Schmitz, Norbert, Maike Nickelsen, Marita Ziepert, et al.. (2011). Conventional chemoimmunotherapy (R-CHOEP-14) or high-dose therapy (R-Mega-CHOEP) for young, high-risk patients with aggressive B-cell lymphoma: Final results of the randomized Mega-CHOEP trial of the German High-Grade Non-Hodgkin Lymphona Study Group (DSHNHL).. Journal of Clinical Oncology. 29(15_suppl). 8002–8002. 17 indexed citations

Basara, Nadežda, Antina Schulze, Ulrich Wedding, et al.. (2009). Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission. Leukemia. 23(4). 635–640. 63 indexed citations

Schöffski, Patrick, Ahmad Awada, Herlinde Dumez, et al.. (2008). 36 ORAL A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours. European Journal of Cancer Supplements. 6(12). 14–15. 8 indexed citations

Reiser, Marcel, Michael Wenger, Christina Nickenig, et al.. (2006). Serum Levels and Pharmacokinetic of Rituximab in Bi-Weekly R-CHOP in Elderly Patients with DLBCL Treated in the RICOVER-60 Trial.. Blood. 108(11). 2748–2748. 3 indexed citations

Reiser, Marcel, Michael Wenger, Christina Nickenig, et al.. (2006). Serum levels and pharmacokinetic of rituximab in Bi-weekly R-CHOP in elderly patients with DLBCL treated in the RICOVER-60 trial:. Journal of Clinical Oncology. 24(18_suppl). 7537–7537. 9 indexed citations

Rosen, O., H.-J. Müller, Nicola Gökbuget, et al.. (2003). Pegylated asparaginase in combination with high‐dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study. British Journal of Haematology. 123(5). 836–841. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact